tiprankstipranks
Advertisement
Advertisement

Nova Leap Posts Record 2025 Results as It Expands Into Broader Community-Based Care

Story Highlights
  • Nova Leap delivered record 2025 revenue and EBITDA while maintaining low leverage and avoiding new equity issuance, strengthening its financial profile and focus on per-share value creation.
  • The company is evolving from a traditional home care provider into a broader community-based care organization, adding care management, palliative care and planned private nursing to deepen services and support growth.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.

Claim 55% Off TipRanks

An announcement from Nova Leap Health ( (TSE:NLH) ) is now available.

Nova Leap Health reported its strongest year on record in 2025, with consolidated revenue rising 22.2% to $31.5 million and adjusted EBITDA up 31.0% to $2.05 million, achieved while keeping leverage low and without issuing new equity since 2022. Management emphasized a deliberate growth strategy centered on cash flow and balance sheet strength, highlighting that recent performance has enhanced the company’s financial profile and supported per-share value creation.

Beyond the numbers, the company is repositioning from a pure home care provider to a broader community-based care organization organized around four complementary pillars: home care, care management, palliative care and forthcoming private nursing. New care management and palliative care divisions, along with the planned launch of private nursing in 2027 and targeted investment in clinically rich markets and existing regions, are intended to expand Nova Leap’s role across the continuum of care and improve both growth prospects and operating efficiency amid rising demand for home and community services.

The most recent analyst rating on (TSE:NLH) stock is a Hold with a C$0.31 price target. To see the full list of analyst forecasts on Nova Leap Health stock, see the TSE:NLH Stock Forecast page.

Spark’s Take on TSE:NLH Stock

According to Spark, TipRanks’ AI Analyst, TSE:NLH is a Neutral.

The score is driven primarily by improving fundamentals—revenue growth, a conservative balance sheet, and positive free cash flow with solid earnings quality—tempered by margin compression and a recently inconsistent earnings history. Technicals are a notable drag with the stock trading below key moving averages and negative MACD, while valuation is middling with a ~23x P/E and no dividend data.

To see Spark’s full report on TSE:NLH stock, click here.

More about Nova Leap Health

Nova Leap Health Corp. operates in the home-based and community-based healthcare sector, historically focused on providing recurring, cash-generating home care services. The company is now broadening its scope into a community-based care model built around four service pillars: home care, care management, palliative care and, starting in 2027, private nursing, with selective investment in key markets to deepen clinical capabilities and regional density.

Average Trading Volume: 23,164

Technical Sentiment Signal: Buy

Current Market Cap: C$27.07M

See more data about NLH stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1